Haemonetics Corp/ US4050241003 /
| 2024-04-26 10:10:00 PM | Chg. +3.33 | Volume | Bid1:18:02 AM | Ask1:18:02 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 90.99USD | +3.80% | 749,023 Turnover: 44.28 mill. |
90.65Bid Size: 100 | 91.44Ask Size: 100 | 4.62 bill.USD | - | 40.08 |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 257 | 271.4370 | 321.9480 | 337.6340 | 323.8620 | ||||||
| Intangible Assets | 264.4000 | 271.1590 | 244.5880 | 204.4580 | 177.5400 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | 891.2020 | 915.1400 | 831.0420 | 728.6800 | ||||||
| Inventories | 183.8000 | 197.6610 | 211.0770 | 187.0280 | 176.9290 | ||||||
| Accounts Receivable | 170.1000 | 164.6030 | 145.8270 | 157.0930 | 152.6830 | ||||||
| Cash and Cash Equivalents | 179.1000 | 192.4690 | 160.6620 | 115.1230 | 139.5640 | ||||||
| Current Assets | 597 | 622.9760 | 570.2770 | 488.0860 | 510.0290 | ||||||
| Total Assets | 1,461.9000 | 1,514.1780 | 1,485.4170 | 1,319.1280 | 1,238.7090 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 49.9000 | 53.5620 | 48.4250 | 39.6740 | 42.9730 | ||||||
| Long-term debt | - | 392.0570 | 406.3690 | 364.5290 | 253.6250 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 29.6000 | 29.7000 | 32.1000 | 21.4000 | 12.1000 | ||||||
| Liabilities | 692.7000 | 676.2900 | 659.2950 | 597.5630 | 499.0990 | ||||||
| Share Capital | .5100 | .5200 | .5170 | .5090 | .5230 | ||||||
| Total Equity | 769.2000 | 837.8880 | 826.1220 | 721.5650 | 739.6100 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1,461.9000 | 1,514.1780 | 1,485.4170 | 1,319.1280 | 1,238.7090 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 892 | 938.5090 | 910.3730 | 908.8320 | 886.1160 | ||||||
| Depreciation (total) | - | 81.7400 | 86.0530 | 89.9110 | 89.7330 | ||||||
| Operating Result | 56.5000 | 47.3270 | 40.5400 | -43.9420 | -19.3810 | ||||||
| Interest Income | - | -10.9260 | -9.3750 | -9.4740 | -8.0950 | ||||||
| Income Before Taxes | 49.9000 | 36.4010 | 31.1650 | -53.4160 | -27.4760 | ||||||
| Income Taxes | 11.1000 | 1.2530 | 14.2680 | 2.1630 | -1.2080 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 38.8000 | 35.1480 | 16.8970 | -55.5790 | -26.2680 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 85.1000 | 139.5240 | 127.1780 | 121.8650 | 159.7380 | ||||||
| Cash Flow from Investing Activities | -596.4000 | -105.8300 | -121.7680 | -104.7680 | -73.3130 | ||||||
| Cash Flow from Financing | 461.9000 | -20.7000 | -33.1600 | -62.6240 | -60.4130 | ||||||
| Decrease / Increase in Cash | -49.7000 | 13.3490 | -31.8070 | -45.5390 | 24.4410 | ||||||
| Employees | 3,563 | 3,782 | 3,383 | 3,225 | 3,107 | ||||||
